• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球人类带绦虫/囊虫感染趋势的感染力变化。

Global variation in force-of-infection trends for human T taeniasis/cysticercosis.

机构信息

Department of Infectious Disease Epidemiology and London Centre for Neglected Tropical Disease Research (LCNTDR), Faculty of Medicine, School of Public Health, Imperial College London, London, United Kingdom.

MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology Faculty of Medicine, School of Public Health, Imperial College London, London, United Kingdom.

出版信息

Elife. 2022 Aug 19;11:e76988. doi: 10.7554/eLife.76988.

DOI:10.7554/eLife.76988
PMID:35984416
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9391040/
Abstract

Infection by poses a major burden across endemic countries. The World Health Organization (WHO) 2021-2030 Neglected Tropical Diseases roadmap has proposed that 30% of endemic countries achieve intensified control in hyperendemic areas by 2030. Understanding geographical variation in age-prevalence profiles and force-of-infection (FoI) estimates will inform intervention designs across settings. Human taeniasis (HTT) and human cysticercosis (HCC) age-prevalence data from 16 studies in Latin America, Africa, and Asia were extracted through a systematic review. Catalytic models, incorporating diagnostic performance uncertainty, were fitted to the data using Bayesian methods, to estimate rates of antibody (Ab)-seroconversion, infection acquisition and Ab-seroreversion or infection loss. HCC FoI and Ab-seroreversion rates were also estimated across 23 departments in Colombia from 28,100 individuals. Across settings, there was extensive variation in all-ages seroprevalence. Evidence for Ab-seroreversion or infection loss was found in most settings for both HTT and HCC and for HCC Ab-seroreversion in Colombia. The average duration until humans became Ab-seropositive/infected decreased as all-age (sero)prevalence increased. There was no clear relationship between the average duration humans remain Ab-seropositive and all-age seroprevalence. Marked geographical heterogeneity in transmission rates indicate the need for setting-specific intervention strategies to achieve the WHO goals.

摘要

在流行地区,寄生虫感染造成了重大负担。世界卫生组织(WHO)2021-2030 年被忽视热带病路线图提出,到 2030 年,30%的流行地区在高度流行地区实现强化控制。了解年龄流行率分布和感染率(FoI)估计的地理差异将为各地区的干预设计提供信息。通过系统评价,从拉丁美洲、非洲和亚洲的 16 项研究中提取了人类带绦虫病(HTT)和人类囊尾蚴病(HCC)的年龄流行率数据。采用贝叶斯方法,将包含诊断性能不确定性的催化模型拟合到数据中,以估计抗体(Ab)-血清转化率、感染获得率和 Ab 血清转化率或感染损失率。还从哥伦比亚的 23 个部门的 28100 个人中估计了 HCC 的 FoI 和 Ab 血清转化率。在所有环境中,所有年龄段的血清阳性率都存在广泛的差异。在大多数环境中,无论是 HTT 还是 HCC,以及在哥伦比亚的 HCC Ab 血清转化率,都发现了 Ab 血清转化率或感染损失的证据。人类开始 Ab 血清阳性/感染的平均持续时间随着全年龄(血清)流行率的增加而缩短。人类保持 Ab 血清阳性的平均持续时间与全年龄血清流行率之间没有明显的关系。传播率的明显地理异质性表明,需要制定特定于环境的干预策略来实现世卫组织的目标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/82a9ca431b1f/elife-76988-fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/b81e55e42e09/elife-76988-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/32a03603877a/elife-76988-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/c0e1814469c7/elife-76988-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/747f9d9fa5af/elife-76988-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/83a36b433c9a/elife-76988-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/f69d4b8347c4/elife-76988-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/d68952c842de/elife-76988-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/fbf6695e1242/elife-76988-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/8c0d0a48b653/elife-76988-fig6-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/290d19a25a12/elife-76988-fig6-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/52ff341ed3d9/elife-76988-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/f335f8edec6b/elife-76988-fig7-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/22da2fdd2cd7/elife-76988-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/417c2a5dd65b/elife-76988-fig8-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/cbe807d79ae9/elife-76988-fig8-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/e835cfe831c1/elife-76988-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/82a9ca431b1f/elife-76988-fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/b81e55e42e09/elife-76988-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/32a03603877a/elife-76988-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/c0e1814469c7/elife-76988-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/747f9d9fa5af/elife-76988-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/83a36b433c9a/elife-76988-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/f69d4b8347c4/elife-76988-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/d68952c842de/elife-76988-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/fbf6695e1242/elife-76988-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/8c0d0a48b653/elife-76988-fig6-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/290d19a25a12/elife-76988-fig6-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/52ff341ed3d9/elife-76988-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/f335f8edec6b/elife-76988-fig7-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/22da2fdd2cd7/elife-76988-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/417c2a5dd65b/elife-76988-fig8-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/cbe807d79ae9/elife-76988-fig8-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/e835cfe831c1/elife-76988-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9391040/82a9ca431b1f/elife-76988-fig10.jpg

相似文献

1
Global variation in force-of-infection trends for human T taeniasis/cysticercosis.全球人类带绦虫/囊虫感染趋势的感染力变化。
Elife. 2022 Aug 19;11:e76988. doi: 10.7554/eLife.76988.
2
Force-of-infection of Taenia solium porcine cysticercosis: a modelling analysis to assess global incidence and prevalence trends.猪囊尾蚴病感染力度:评估全球发病率和流行率趋势的建模分析。
Sci Rep. 2020 Oct 19;10(1):17637. doi: 10.1038/s41598-020-74007-x.
3
Taenia solium taeniasis/cysticercosis: From parasite biology and immunology to diagnosis and control.猪带绦虫病/囊尾蚴病:从寄生虫生物学和免疫学角度探讨诊断和防治。
Adv Parasitol. 2021;112:133-217. doi: 10.1016/bs.apar.2021.03.003. Epub 2021 Apr 8.
4
Spatial and temporal distribution of Taenia solium and its risk factors in Uganda.乌干达猪带绦虫的时空分布及其危险因素
Int J Infect Dis. 2023 Apr;129:274-284. doi: 10.1016/j.ijid.2023.02.001. Epub 2023 Feb 16.
5
Insights into the diagnosis, vaccines, and control of Taenia solium, a zoonotic, neglected parasite.猪带绦虫(一种人畜共患的被忽视寄生虫)的诊断、疫苗和控制的新见解。
Parasit Vectors. 2023 Oct 24;16(1):380. doi: 10.1186/s13071-023-05989-6.
6
Taenia solium Human Cysticercosis: A Systematic Review of Sero-epidemiological Data from Endemic Zones around the World.猪带绦虫人体囊尾蚴病:来自世界各地流行区血清流行病学数据的系统评价
PLoS Negl Trop Dis. 2015 Jul 6;9(7):e0003919. doi: 10.1371/journal.pntd.0003919. eCollection 2015.
7
Taenia solium taeniosis/cysticercosis in Africa: risk factors, epidemiology and prospects for control using vaccination.非洲猪带绦虫绦虫病/囊尾蚴病:危险因素、流行病学及疫苗接种控制前景
Vet Parasitol. 2013 Jul 1;195(1-2):14-23. doi: 10.1016/j.vetpar.2012.12.022. Epub 2012 Dec 20.
8
Consumer knowledge and practices to pork safety in two Taenia solium cysticercosis endemic districts in Eastern Cape Province of South Africa.消费者对南非东开普省两个猪带绦虫囊尾蚴流行区猪肉安全的知识和实践。
BMC Infect Dis. 2020 Feb 6;20(1):107. doi: 10.1186/s12879-020-4839-9.
9
Sero-prevalence of Taenia solium cysticercosis and Taenia solium taeniasis in California, USA.美国加利福尼亚州猪带绦虫囊尾蚴病和猪带绦虫病的血清流行率。
Acta Neurol Scand. 2005 Feb;111(2):84-8. doi: 10.1111/j.1600-0404.2005.00373.x.
10
Control of Taenia solium taeniasis/cysticercosis: The best way forward for sub-Saharan Africa?猪带绦虫病/囊尾蚴病的防控:撒哈拉以南非洲的最佳前进方向?
Acta Trop. 2017 Jan;165:252-260. doi: 10.1016/j.actatropica.2016.04.010. Epub 2016 Apr 29.

引用本文的文献

1
Quantification of tuberculosis exposure in a high-burdened setting.高负担环境下结核病暴露的量化
Sci Rep. 2025 Jul 2;15(1):22687. doi: 10.1038/s41598-024-81558-w.
2
Prevalence of Cysticercosis in Pigs and Risk Assessment Among Occupationally Exposed Workers in Benue State, Nigeria.尼日利亚贝努埃州猪囊尾蚴病的患病率及职业暴露工人的风险评估
Vet Med Sci. 2025 May;11(3):e70367. doi: 10.1002/vms3.70367.
3
Isolated intramuscular cysticercosis of the forearm masquerading as malignancy.前臂孤立性肌间囊虫病伪装为恶性肿瘤。

本文引用的文献

1
Spatial distribution and risk factors for human cysticercosis in Colombia.哥伦比亚人体囊虫病的空间分布及危险因素。
Parasit Vectors. 2021 Nov 27;14(1):590. doi: 10.1186/s13071-021-05092-8.
2
Taenia solium taeniasis/cysticercosis: From parasite biology and immunology to diagnosis and control.猪带绦虫病/囊尾蚴病:从寄生虫生物学和免疫学角度探讨诊断和防治。
Adv Parasitol. 2021;112:133-217. doi: 10.1016/bs.apar.2021.03.003. Epub 2021 Apr 8.
3
Force-of-infection of Taenia solium porcine cysticercosis: a modelling analysis to assess global incidence and prevalence trends.
BMJ Case Rep. 2024 Feb 6;17(2):e256110. doi: 10.1136/bcr-2023-256110.
4
Triplex ELISA for Assessing Durability of Taenia solium Seropositivity after Neurocysticercosis Cure.三抗体 ELISA 法评估脑囊虫病治愈后猪带绦虫血清阳性的持久性。
Emerg Infect Dis. 2023 Jul;29(7):1340-1348. doi: 10.3201/eid2907.230364.
猪囊尾蚴病感染力度:评估全球发病率和流行率趋势的建模分析。
Sci Rep. 2020 Oct 19;10(1):17637. doi: 10.1038/s41598-020-74007-x.
4
Modelling for policy: The five principles of the Neglected Tropical Diseases Modelling Consortium.政策建模:被忽视热带病建模联盟的五项原则
PLoS Negl Trop Dis. 2020 Apr 9;14(4):e0008033. doi: 10.1371/journal.pntd.0008033. eCollection 2020 Apr.
5
Recent advancements in the control of : A systematic review.控制方面的最新进展:一项系统综述。
Food Waterborne Parasitol. 2018 Nov 13;13:e00030. doi: 10.1016/j.fawpar.2018.e00030. eCollection 2018 Dec.
6
Modelling exposure heterogeneity and density dependence in onchocerciasis using a novel individual-based transmission model, EPIONCHO-IBM: Implications for elimination and data needs.利用一种新的基于个体的传播模型 EPIONCHO-IBM 对盘尾丝虫病的暴露异质性和密度依赖性进行建模:对消除的影响和数据需求。
PLoS Negl Trop Dis. 2019 Dec 5;13(12):e0007557. doi: 10.1371/journal.pntd.0007557. eCollection 2019 Dec.
7
The World Health Organization 2030 goals for onchocerciasis: Insights and perspectives from mathematical modelling: NTD Modelling Consortium Onchocerciasis Group.世界卫生组织2030年盘尾丝虫病防治目标:数学建模的见解与观点:被忽视热带病建模联盟盘尾丝虫病小组
Gates Open Res. 2019 Sep 26;3:1545. doi: 10.12688/gatesopenres.13067.1. eCollection 2019.
8
The World Health Organization 2030 goals for : Insights and perspectives from transmission dynamics modelling: CystiTeam Group for Epidemiology and Modelling of Taeniasis/Cysticercosis.世界卫生组织2030年目标:来自传播动力学建模的见解与观点:绦虫病/囊尾蚴病流行病学与建模CystiTeam小组
Gates Open Res. 2019 Sep 26;3:1546. doi: 10.12688/gatesopenres.13068.2. eCollection 2019.
9
Control of ; A Case for Public and Private Sector Investment.对……的控制;公私部门投资的一个案例。 (原文表述不太完整,翻译可能不太准确,最好能提供更完整准确的原文)
Front Vet Sci. 2019 Jun 20;6:176. doi: 10.3389/fvets.2019.00176. eCollection 2019.
10
Strategies for tackling Taenia solium taeniosis/cysticercosis: A systematic review and comparison of transmission models, including an assessment of the wider Taeniidae family transmission models.解决猪带绦虫病/囊尾蚴病的策略:系统评价和比较传播模型,包括对 wider Taeniidae 家族传播模型的评估。
PLoS Negl Trop Dis. 2019 Apr 10;13(4):e0007301. doi: 10.1371/journal.pntd.0007301. eCollection 2019 Apr.